8-K filing — Fathom Holdings Inc. (FTHM)
Filed: 2026-08-25 AccNo: 0001628280-26-058728 Size: 141 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Read original at edgarStocks · News reference
Fathom Holdings Q2 EPS $(0.19) Misses $(0.02) Estimate, Sales $114.612M Beat $25.404M Estimate
Fathom Holdings (NASDAQ:FTHM) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.02) by 850 percent. This is a 46.15 percent decrease over losses of $(0.13) per share from
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 13, 2026, 8:26 PM
- Checked
- Aug 13, 2026, 8:26 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Fathom Holdings Q1 EPS $(0.25) Misses $(0.10) Estimate, Sales $86.401M Miss $93.698M Estimate
Fathom Holdings (NASDAQ:FTHM) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.10) by 150 percent. This is a 4.17 percent decrease over losses of $(0.24) per share from
Read original at benzingaBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Arcosa, Inc. (NYSE – ACA), Fathom Holdings Inc. (Nasdaq – FTHM), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)
Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and provide fair value to shareholders. The investigations involve Arcosa (CRH acquisition for $150/share), Fathom Holdings (Bed Bath & Beyond acquisition), Nuvalent (GSK acquisition for $124/share), and Dana Incorporated (Eaton Corporation acquisition).
Read original at globenewswire-inc